Y
Yinkun Liu
Researcher at Fudan University
Publications - 234
Citations - 7610
Yinkun Liu is an academic researcher from Fudan University. The author has contributed to research in topics: Metastasis & Hepatocellular carcinoma. The author has an hindex of 44, co-authored 230 publications receiving 6867 citations. Previous affiliations of Yinkun Liu include Shanghai Jiao Tong University & Chinese Ministry of Education.
Papers
More filters
Journal ArticleDOI
Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation
Hui Yang,Yinkun Liu,Feng Bai,Jinguo Zhang,Shenghong Ma,Jian Liu,Xu Zd,Hai-Rong Zhu,Ling Zq,Dan Ye,Kun-Liang Guan,Kun-Liang Guan,Yue Xiong,Yue Xiong +13 more
TL;DR: The levels of 5hmC are dramatically reduced in human breast, liver, lung, pancreatic and prostate cancers when compared with the matched surrounding normal tissues and the substantial reduction of the expression of all three TET genes is revealed, revealing a possible mechanism for the reduced5hmC in cancer cells.
Journal ArticleDOI
A decade's studies on metastasis of hepatocellular carcinoma.
Zhao-You Tang,Sheng-Long Ye,Yinkun Liu,Lun-Xiu Qin,Hui-Chuan Sun,Qin-Hai Ye,Lu Wang,Jian Zhou,Shuang-Jian Qiu,Yan Li,Xue-Ning Ji,Hu Liu,Jing-Ling Xia,Zhi-Quan Wu,Jia Fan,Zeng-Chen Ma,Xin-Da Zhou,Zhi-Ying Lin,Kang-Da Liu +18 more
TL;DR: A molecular signature that can classify metastatic HCC patients is generated, osteopontin is identified as a lead gene in the signature, and it is found that genes favoring metastasis progression were initiated in the primary tumors.
Journal ArticleDOI
Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97
TL;DR: Two clones of the same genetic background but with different biological behaviors were established, which could be valuable models for investigation on HCC metastasis.
Journal ArticleDOI
microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity
TL;DR: miR-22, downregulated in HCC, has an anti-proliferative effect on HCC cells both in vitro and in vivo, and may have considerable potential in identification of the prognosis and application of cancer therapy for HCC patients.
Journal ArticleDOI
New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis
TL;DR: A new human hepatocellular carcinoma (HCC) cell line with a highly metastatic potential was established from subcutaneous xenograft of a metastatic model of human HCC in nude mice by means of alternating cell culture in vitro and growth in nude mouse.